0001209191-23-008166.txt : 20230209 0001209191-23-008166.hdr.sgml : 20230209 20230209190923 ACCESSION NUMBER: 0001209191-23-008166 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230207 FILED AS OF DATE: 20230209 DATE AS OF CHANGE: 20230209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Farid Ramy CENTRAL INDEX KEY: 0001797707 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41608 FILM NUMBER: 23607931 MAIL ADDRESS: STREET 1: SCHRODINGER, INC. STREET 2: 120 WEST 45TH STREET, 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Structure Therapeutics Inc. CENTRAL INDEX KEY: 0001888886 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981480821 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 611 GATEWAY BLVD SUITE 223 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (628) 229-9277 MAIL ADDRESS: STREET 1: 611 GATEWAY BLVD SUITE 223 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: ShouTi Inc. DATE OF NAME CHANGE: 20211019 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-07 0 0001888886 Structure Therapeutics Inc. GPCR 0001797707 Farid Ramy C/O STRUCTURE THERAPEUTICS INC. 611 GATEWAY BLVD., SUITE 223 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Ordinary Shares 2023-02-07 4 C 0 642245 A 3260495 I By Schrodinger, Inc. Series B Preferred Shares 2023-02-07 4 C 0 642245 D Ordinary Shares 642245 0 I By Schrodinger, Inc. American Depositary Shares 2023-02-07 4 P 0 275000 15.00 A Ordinary Shares 825000 275000 I By Schrodinger, Inc. All outstanding Preferred Shares automatically converted into Ordinary Shares immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one Ordinary Share for each one Preferred Share, based on the conversion price currently in effect. The Preferred Shares have no expiration date. The Reporting Person is President, Chief Executive Officer and a member of the board of directors of Schrodinger, Inc. ("Schrodinger") and may be deemed to share voting and dispositive power over the shares held by Schrodinger. The Reporting Person disclaims beneficial ownership of the shares held by Schrodinger. Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. The American Depositary Shares were purchased in the Issuer's initial public offering. /s/ Jun Yoon, Attorney-in-Fact 2023-02-09